{
    "code": "01049008",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01049008",
    "time": "2019-12-13 03:04:52",
    "許可證字號": "衛署藥製字第049008號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/08\/31",
    "發證日期": "96\/08\/31",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104900809",
    "中文品名": "“生達”健立達錠 50 毫克",
    "英文品名": "Citazol Tablets 50mg“Standard”",
    "適應症": "使用於無休息時疼痛及周邊組織壞死之間歇性跛行病人（周邊動脈疾病Fontaine stage II），用於增加最大及無痛行走距離及經生活模式改變（包含戒菸及運動計畫）及其他治療後，仍無法充分改善間歇性跛行症狀病人之二線治療。無法耐受aspirin且屬非心因性栓塞之腦梗塞患者，以預防腦梗塞之再復發。",
    "劑型": "110錠劑",
    "包裝": "4~1000錠PTP 鋁箔盒裝 塑膠瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 25監視中學名藥 61完成BE試驗",
        "申請商名稱": "0510620200  生達化學製藥股份有限公司",
        "申請商地址": "台南市新營區土庫里土庫6之20號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005500",
            "成分名稱": "CILOSTAZOL",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Citazol Tab-104-11-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049008&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "010490080001_20170526-106-06-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049008&Seq=005&Type=9"
        },
        {
            "title": "Citazol 健立達 LT-104-11-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049008&Seq=004&Type=9"
        },
        {
            "title": "010490080003_20170526-106-06-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049008&Seq=012&Type=8"
        },
        {
            "title": "010490080002_20170526-106-06-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049008&Seq=011&Type=8"
        },
        {
            "title": "010490080001_20170526-106-06-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049008&Seq=010&Type=8"
        },
        {
            "title": "2712995_S0309 健立達-60錠-BX-104-11-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049008&Seq=009&Type=8"
        }
    ]
}